Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force
Rhabdomyosarcoma is the most common soft tissue sarcoma diagnosed in children and adolescents. Patients that are diagnosed with advanced or relapsed disease have exceptionally poor outcomes. The Children’s Oncology Group (COG) convened a rhabdomyosarcoma new agent task force in 2020 to systematicall...
Main Authors: | Holly L. Pacenta, Wendy Allen-Rhoades, David Langenau, Peter J. Houghton, Charles Keller, Christine M. Heske, Michael D. Deel, Corinne M. Linardic, Jack F. Shern, Elizabeth Stewart, Brian Turpin, Douglas J. Harrison, Javed Khan, Leo Mascarenhas, Stephen X. Skapek, William H. Meyer, Douglas S. Hawkins, Eleanor Y. Chen, James F. Amatruda, Pooja Hingorani, Theodore W. Laetsch |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/7/1416 |
Similar Items
-
Relapsed Rhabdomyosarcoma
by: Christine M. Heske, et al.
Published: (2021-02-01) -
Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: Utility and pitfalls
by: Ashley R.P. Hinson, et al.
Published: (2013-07-01) -
Embryonal Rhabdomyosarcoma of the Mandible
by: Rodante A. Roldan, et al.
Published: (2005-11-01) -
Alveolar Rhabdomyosarcoma of Oral Cavity – A Rare Case
by: Ravi Batra, et al.
Published: (2010-07-01) -
Rhabdomyosarcoma of the bladder
by: P M Deka, et al.
Published: (2001-01-01)